It is deeply unfortunate that we head into Fall without enough doses of this drug. Many of us were talking about this as early as March. Regeneron did extraordinary work to secure their own manufacturing, but we needed a concerted industrial effort to get the supply we needed. https://twitter.com/megtirrell/status/1321558486271053825">https://twitter.com/megtirrel...

Re-upping this July Op Ed. Some of the same opportunities we identified here are still open to us. But we need to start taking steps immediately to have enough of these drugs to use as a backstop for high risk patients; and a bridge until we get a vaccine. https://www.wsj.com/articles/antibodies-can-be-the-bridge-to-a-vaccine-11593969735">https://www.wsj.com/articles/...

Re-upping this April Op Ed. https://www.wsj.com/articles/bet-big-on-treatments-for-coronavirus-11586102963">https://www.wsj.com/articles/...

https://twitter.com/ScottGottliebMD/status/1247357901452214272">https://twitter.com/ScottGott...